Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
PrEP, or pre-exposure prophylaxis, was first approved by the FDA in 2012 to prevent people exposed to HIV from becoming ...
Unlike oral PrEP treatments, which are taken daily, the drug is administered at six-month intervals and is the longest acting injectable produced to date. In a late-stage trial, lenacapavir reduced ...
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...